Ignite Creation Date:
2025-12-24 @ 3:43 PM
Ignite Modification Date:
2026-03-06 @ 2:31 PM
Study NCT ID:
NCT00749892
Status:
COMPLETED
Last Update Posted:
2020-09-10
First Post:
2008-09-05
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Erlotinib Hydrochloride in Treating Participants With Muscle Invasive or Recurrent Urothelial Cancer
Sponsor:
M.D. Anderson Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-06-10
Start Date Type:
ACTUAL
Primary Completion Date:
2019-06-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-11-26
Completion Date Type:
ACTUAL
First Submit Date:
2008-09-05
First Submit QC Date:
None
Study First Post Date:
2008-09-09
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2020-06-05
Results First Submit QC Date:
None
Results First Post Date:
2020-09-10
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-08-21
Last Update Post Date:
2020-09-10
Last Update Post Date Type:
ACTUAL